NCT05012709

Brief Summary

Design: This parallel randomized controlled trial (RCT) was conducted according to the Consolidated Standards of Reporting Trials (CONSORT). Methods: In total, 90 patients were randomly assigned to either the intervention or the control group. After a 2-week washout period, the intervention group was reassigned to the control and vice versa. The CONSORT checklist for RCT was reported. Psychotic symptoms, emotional reactions, behavioral relaxation responses and heart rates were assessed at 6 time points.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 15, 2012

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2013

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2013

Completed
8.4 years until next milestone

First Submitted

Initial submission to the registry

August 11, 2021

Completed
8 days until next milestone

First Posted

Study publicly available on registry

August 19, 2021

Completed
Last Updated

August 19, 2021

Status Verified

August 1, 2021

Enrollment Period

10 months

First QC Date

August 11, 2021

Last Update Submit

August 12, 2021

Conditions

Outcome Measures

Primary Outcomes (4)

  • Change of Psychiatric Symptoms

    Brief Psychiatric Rating Scale (BPRS) consists of a series of 18 items that are used to assess the following psychotic symptoms: somatic concern, anxiety, emotional withdrawal, conceptual disorganization, guilt feelings, tension, mannerisms and posturing, grandiosity, depressive mood, hostility, suspiciousness, hallucinatory behavior, motor retardation, uncooperativeness, unusual thought content, blunted affect, excitement, and disorientation (Overall and Gorham, 1962). The total score range is between 0 (not present) and 18 (extremely severe). The reliability of BPRS in this study was acceptable (Cronbach's α = 0.71).

    Change from baseline BPRS at the sixth sessions (each session is 7 days).

  • Change of Anxiety

    The Hospital Anxiety and Depression Scale-Anxiety subscale (HADS-A) includes seven items. Each item is evaluated on a four-point (0 to 3) scale, with a total possible score range of 0 to 21. Scores of eight and higher indicate the possible presence of anxiety. The reliability of HADS-A in this study was acceptable (Cronbach's α = 0.67).

    Change from baseline HADS-A at the sixth sessions (each session is 7 days).

  • Change of Behavioral Relaxation

    Behavioral Relaxation Scale (BRS) was administered to measure the motor elements of relaxation through observations of voluntary muscles by trained clinicians. Ten dimensions of postures were observed (e.g. breath, shoulders, hands… etc.) and behaviors were checked for indications of relaxation. The total score range of the BRS is between 0 (no relaxation) and 10 (relaxation).

    Change from baseline BRS at the sixth sessions (each session is 7 days).

  • Change of physiological responses

    Patients' Heart Rate, as an indicator of their responses to stress and tension, was measured by a wireless biofeedback system (MindMedia, Herten). The data was collected at a rate of 400 importing signals every minute.

    Change from baseline heart rate at the sixth sessions (each session is 7 days).

Study Arms (2)

intervention group

EXPERIMENTAL

The intervention group received six 30-minute MST sessions. During MST session, participants can choose their preferred sensory stimuli such as essential oil diffuses, music and so on.

Behavioral: multisensory stimulation therapy

control group

NO INTERVENTION

The TAU group received usual routine care.

Interventions

The intervention group received six 30-minute MST sessions. During MST session, participants can choose their preferred sensory stimuli such as essential oil diffuses, music and so on.

intervention group

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • hospitalized patients
  • diagnosed with schizophrenia, schizophreniform disorder, and schizoaffective disorder for more than 5 years according to Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (American Psychiatric Association, 2013).
  • aged above 20 years old

You may not qualify if:

  • had a history of alcohol and drug abuse
  • could not concentrate on activities for at least 30 minutes.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mei-Feng, Lin

Tainan, 70101, Taiwan

Location

Related Publications (7)

  • American Psychiatric Association. (2013). Quick reference to the diagnostic criteria from DSM-V (p. 370). Washington, DC: APA.

    BACKGROUND
  • Overall, J. E., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological reports, 10(3), 799-812. https://doi.org/10.2466%2Fpr0.1962.10.3.799

    BACKGROUND
  • Snaith RP. The Hospital Anxiety And Depression Scale. Health Qual Life Outcomes. 2003 Aug 1;1:29. doi: 10.1186/1477-7525-1-29.

    PMID: 12914662BACKGROUND
  • Michultka DM, Poppen RL, Blanchard EB. Relaxation training as a treatment for chronic headaches in an individual having severe developmental disabilities. Biofeedback Self Regul. 1988 Sep;13(3):257-66. doi: 10.1007/BF00999174.

    PMID: 3067751BACKGROUND
  • Cheng SC, Hsu WS, Shen SH, Hsu MC, Lin MF. Dose-Response Relationships of Multisensory Intervention on Hospitalized Patients With Chronic Schizophrenia. J Nurs Res. 2017 Feb;25(1):13-20. doi: 10.1097/jnr.0000000000000154.

    PMID: 27310606BACKGROUND
  • Juszczak E, Altman DG, Hopewell S, Schulz K. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement. JAMA. 2019 Apr 23;321(16):1610-1620. doi: 10.1001/jama.2019.3087.

    PMID: 31012939BACKGROUND
  • Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. Trials. 2010 Mar 24;11:32. doi: 10.1186/1745-6215-11-32.

    PMID: 20334632BACKGROUND

MeSH Terms

Conditions

Psychotic DisordersAnxiety Disorders

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental Disorders

Study Officials

  • Mei-Feng Lin, PhD

    National Cheng Kung University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Model Details: In total, 90 patients were randomly assigned to either the intervention or the control group. After a 2-week washout period, the intervention group was reassigned to the control and vice versa.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RN, Professor, Department of Nursing, College of Medicine, National Cheng Kung University

Study Record Dates

First Submitted

August 11, 2021

First Posted

August 19, 2021

Study Start

March 15, 2012

Primary Completion

January 10, 2013

Study Completion

March 10, 2013

Last Updated

August 19, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Not shared with other research teams.

Locations